To support the development and commercialization of a novel immunotherapy, biopharmaceutical company TG Therapeutics has signed a deal to license MaxCyte’s Flow Electroporation® technology and ExPERT™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results